|
THAP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.965600E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.349920E-02 |
| Normal-vs-Stage2 |
1.352780E-01 |
| Normal-vs-Stage3 |
1.67799999994944E-06 |
| Normal-vs-Stage4 |
1.045180E-04 |
| Stage1-vs-Stage2 |
9.675200E-01 |
| Stage1-vs-Stage3 |
7.598500E-04 |
| Stage1-vs-Stage4 |
3.050200E-02 |
| Stage2-vs-Stage3 |
9.340100E-02 |
| Stage2-vs-Stage4 |
2.392600E-01 |
| Stage3-vs-Stage4 |
4.624000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.163400E-04 |
| Normal-vs-AfricanAmerican |
1.36910000003709E-06 |
| Normal-vs-Asian |
1.530390E-01 |
| Caucasian-vs-AfricanAmerican |
8.163200E-03 |
| Caucasian-vs-Asian |
8.889600E-01 |
| AfricanAmerican-vs-Asian |
3.908200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.392600E-04 |
| Normal-vs-Female |
8.901900E-03 |
| Male-vs-Female |
1.936210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.716900E-03 |
| Normal-vs-Age(41-60Yrs) |
5.795800E-03 |
| Normal-vs-Age(61-80Yrs) |
5.6170000000022E-05 |
| Normal-vs-Age(81-100Yrs) |
1.358470E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.612000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.104200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.330600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.673040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.755200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.797200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.069400E-01 |
| Normal-vs-Grade 2 |
9.390500E-02 |
| Normal-vs-Grade 3 |
5.214899999606E-07 |
| Normal-vs-Grade 4 |
1.28289999956621E-07 |
| Grade 1-vs-Grade 2 |
3.226600E-01 |
| Grade 1-vs-Grade 3 |
4.120600E-03 |
| Grade 1-vs-Grade 4 |
9.589400E-04 |
| Grade 2-vs-Grade 3 |
1.024160E-04 |
| Grade 2-vs-Grade 4 |
1.71720999999625E-05 |
| Grade 3-vs-Grade 4 |
9.067800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.142400E-01 |
| Normal-vs-ccB subtype |
1.30870000003558E-06 |
| ccA subtype-vs-ccB subtype |
3.77290000019848E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.024200E-03 |
| Normal-vs-N1 |
1.129810E-02 |
| N0-vs-N1 |
4.482000E-01 |
|
|
